2023 Virtual Series:
Psychiatry in the 21st Century: Where Might the Future Take Us?
Join us as we explore advances in modern psychiatric treatments straight from the experts. Expect to hear about a range of topics from interventional psychiatry updates and the new TAAR1 receptor to updates on the current state of cannabis and psychedelic research.
This is a 4-part series with sessions falling on the last Thursday of the month between January and April 2023. Sessions will run from 6:30-8 p.m.
Sessions:
Session 1: Advances in Therapeutic Neuromodulation
January 26, 2023
Guest Speaker: Philip G. Janicak, MD
Dr. Philip Janicak is an Adjunct Professor and Consultant to the Therapeutic Neuromodulation Program in the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine and a Distinguished Life Fellow in the American Psychiatric Association. He completed his medical training and psychiatric residency at Loyola University of Chicago in 1976. In 1978, he became a research psychiatrist at the Illinois State Psychiatric Institute. He was a Professor of Psychiatry and Pharmacology, the Medical Director of the Psychiatric Clinical Research Center, and the Associate Program Director for the NIH General Clinical Research Center at the University of Illinois Medical Center from 1994-2004. He then became a Professor of Psychiatry at Rush University and was the Director of the Rush Psychiatric Clinical Research and Transcranial Magnetic Stimulation Centers from 2004-2014. He developed and directed the TMS Center at Linden Oaks Medical Group from 2014-2017. Dr. Janicak’s primary research interests are in the assessment and treatment of mood and psychotic disorders. In this context, he has conducted over 60 clinical trials. He has been a NIH grant awardee as both a principal and co-investigator. He has authored, co-authored or edited over 500 publications in the psychiatric literature and is first author of the Principles and Practice of Psychopharmacotherapy. Dr. Janicak was the editor of the Psychopharm Review from 2004-2014 and presently serves on the Editorial Board of Current Psychiatry. He has also been a reviewer for several journals, including: The American Journal of Psychiatry, Biological Psychiatry, JAMA Psychiatry, Journal of the American Medical Association, Journal of ECT, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, Psychiatric Annals, Psychiatry Research and Schizophrenia Research. Dr. Janicak was first listed in the Best Doctors of America since 1996 and Who’s Who in America in 2001. Dr. Janicak was named Psychiatrist of the Year by NAMI Illinois for 2003. In 2009, he received the John M. Davis Researcher of the Year Award from NAMI of Greater Chicago. In 2017, he was a recipient of the Who’s Who Albert Nelson Marquis Lifetime Achievement Award. In 2018, he was the recipient of the Illinois Psychiatric Society Educator of the Year Award. He has participated as a principal lecturer in over 500 courses, seminars, symposia and related professional presentations.
Session 2: Back to the Future: Psychedelics in Psychiatry
February 23, 2023
Guest Speaker: Fernando Espi Forcen, MD, PhD
Dr. Fernando Espi Forcen has been advanced to Assistant Professor of Psychiatry based on clinical innovations in psychedelics. He graduated from medical school in his hometown at the University of Murcia, Spain. At the same university he read a PhD on the history of mental health in the Middle Ages and early moderl period. Due to the number of publications resulting from this work he was awarded the best PhD award in Health Science at the same university. Fernando came to the United States to train in general psychiatry at MetroHealth Medical Center Cleveland, child psychiatry at the University of Chicago and psycho-oncology at Memorial Sloan Kettering. He worked at Rush University in Chicago for five years where he was awarded teacher of the year at the residency program three times. Following his departure from Rush the teaching award was renamed Dr. Espi residency teaching award. At MGH, Fernando has been nominated to the Borus teaching award two consecutive times and has been granted the clinical mentor award at the residency program this year. Fernando has presented at many major psychiatric conferences nationally and internationally and has published over 35 peer reviewed, 16 non peer reviewed articles, 6 book chapters, and 2 books in different areas of psychiatry like psychedelics, history of psychiatry, akathisia, catatonia, psycho-oncology, media and cinema. He is a reviewer for 19 scientific journals and an editor for 3 journals. He founded the journal of humanistic psychiatry and the podcast el último humanista with 20,000 followers.
Session 3: TAAR1: Science Behind a Potential New TAARget for Schizophrenia
March 30, 2023
Guest Speaker: LaGenia Bailey, PharmD
Dr. LaGenia Bailey holds a Doctorate in Pharmacy and is Board Certified in Psychiatric Pharmacy. She is Director, MSL and National Lead for patient centricity and engagement for the Medical Scientific Affairs in Psychiatry, Sunovion Pharmaceuticals, Inc. She has been on development teams for three new antipsychotics. Dr. Bailey brings her experience as a clinician, researcher and advocate to this presentation. She received her doctorate in Pharmacy from University of Illinois, completed a residency and fellowship in psychopharmacology at UMKC and Greater Kansas City Research Foundation. A former Clinical Associate Professor at University of Illinois she coordinated the research program, treatment resistant Schizophrenia program, clozapine clinic, movement disorders and a consult-liaison psychopharmacology team. Dr. Bailey has been a member of NAMI for 35 years and has lived experience of 4 family members with a diagnosis of Schizophrenia. She has served on the national boards of Directors for The Depression and Bipolar Support Alliance and This is My Brave. Dr. Bailey is a yoga therapist and has taught yoga and meditation practices for the last 22 years internationally, nationally, regionally and locally including for NAMI and DBSA and for the women’s program at Cook County Jail. Her mission is to decrease the suffering and empower recovery for all people with a diagnosis of SMI and their families.
Session 4: Current State of Cannabis in Psychiatry
April 27, 2023
Guest Speaker: Jesse D. Hinckley, MD, PhD
Dr. Jesse Hinckley graduated magna cum laude with his bachelor of science in neuroscience from Brigham Young University in 2005. After a short stent as a data analyst for the Combined DNA Index System (CODIS) at Myriad Genetics, he matriculated into the Medical Scientist Training Program at the University of Iowa. Dr. Hinckley transferred to the University of Colorado School of Medicine in 2008, and he graduated with his MD and PhD in Human Medical Genetics and Genomics in 2015. Upon graduation, Dr. Hinckley remained at the University of Colorado, where he completed his general psychiatry residency and child and adolescent psychiatry fellowship. Dr. Hinckley joined the faculty at the University of Colorado thereafter. He is an assistant professor in the Division of Addiction Research, Treatment & Prevention within the Department of Psychiatry. Dr. Hinckley currently serves as the Director of Adolescent Psychiatric Services for the Addiction Research and Treatment Services program and Associate Medical Director of psychiatric emergency services at UCHealth. He is co-founder and co-director of the Addiction Biology Lab at the University. Dr. Hinckley’s primary research interests include better understanding the development of substance use disorders in adolescents, the interaction between substance use problems and mental health disorders, and how to effectively treat comorbid disorders. He is particularly interested in better understanding the biology of how cannabis use affects the developing adolescent. Dr. Hinckley and his wife are foster parents, adding to his understanding and appreciation of how substance use affects teenagers and their families. Dr. Hinckley is the recipient of multiple awards, including the National Institute on Drug Abuse and American Academy of Child and Adolescent Psychiatry Resident Training Award in Substance Use Disorders and is currently conducting research as a recipient of the AACAP Physician Scientist Program in Substance Use K12 Career Development Award. He is also co-investigator of a NIDA-funded R01 comparing two therapeutic interventions for adolescents with co-occurring PTSD and substance use problems. Outside of professional responsibilities, Dr. Hinckley is an avid choral musician, wildlife photographer, dog breeder and trainer, and bibliophile.
